List of Current Trials

To have your clinical trial included in our list, please complete the Clinical Trial Information Form

PIs

Study Title

Anastasia Amaro, MD

Pivotal Aspiration Therapy with Adjusted Lifestyle (PATHWAY) Study

Anastasia Amaro, MD A Randomized Phase 2, Double-blind, Placebo-controlled, Treat-to-Target, Parallel-group, 3-arm, Multicenter Study to Assess the Efficacy and Safety of Canagliflozin as Add-on Therapy to Insulin in the Treatment of Subjects with Type 1 Diabetes Mellitus

Anne Cappola, MD, MS

Ghrelin Plus Resistance Training in Frail Elderly Study

Struan Grant, PhD

A Study of the Genetic Causes of Latent Autoimmune Diabetes in Adults

Andrea Kelly, MD, MS & Michael Rickels, MD, MS

Determination of Beta-Cell Responsiveness to the Incretin Hormones GLP-1 and GIP in Cystic Fibrosis (Aim 1)

Andrea Kelly, MD, MS & Michael Rickels, MD, MS

A Randomized, Double Blind, Placebo Controlled Study of the Effectiveness of Chronic Incretin-Based Therapy on Insulin Secretion in Cystic Fibrosis (Aim 2)

Andrea Kelly, MD & Michael Rickels, MD, MS

Evaluation of the enteroinsular axis in cystic fibrosis (Aim 3 Genetics)

Ali Naji, MD, PhD & Michael Rickels, MD, MS

Islet Cell Transplantation in Type 1 Diabetes

Ali Naji, MD, PhD & Michael Rickels, MD, MS

Islet Transplantation versus Standard Medical Therapy in Type 1 Diabetic Kidney Allograft Recipients

Michael Rickels, MD, MS Adrenergic Contribution To Glucose Counterregulation In Islet Transplantation

Michael Rickels, MD, MS

Effect of Real-Time Continuous Glucose Monitoring on Glucose Counterregulation in Long Standing Type 1 Diabetes

Michael Rickels, MD, MS

Type 1 Diabetes Exchange Clinic-Based Registry Network

Michael Rickels, MD, MS

Residual C-peptide in Patients with Type 1 Diabetes

Michael Rickels, MD, MS

The Effect of Short Term Atypical Antipsychotic Administration Compared to Placebo on Hepatic Insulin Extraction and Muscarinic Mediation of Beta-Cell Function: A Small Mechanistic, Single-Site Study

Raymond Soccio, MD, PhD

Human Adipose Resource of IDOM

Peter Snyder, MD A Randomized, Double-blind, Multicenter, Phase 111 Study to Evaluate the Efficacy and Safety of Pasireotide LAR in Patients with Cushing’s Disease
Peter Snyder, MD Treatment for Endogenous Cushing's Syndrome
Peter Snyder, MD Safety and Efficacy of LCI699 for the treatment of Patients with Cushing's disease
Peter Snyder, MD Trial to compare the efficacy and safety of NNC195-0092 with placebo and Norditropin Flex Pro in Adults with growth hormone deficiency.

Mark Schutta, MD

Epidemiology of Diabetes Interventions and Complications Study (EDIC STUDY)